Vulnerability in Medtronic Paradigm Wireless Insulin Pump

CVE-2011-3386

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

Published · last modified .

CVSS v2 metric

CVSS v2 base score 4.0 (Medium). Vector: AV:N/AC:H/Au:N/C:N/I:P/A:P. This CVE predates CVSS v3 and has no v3 score from NVD.

EPSS exploit prediction

EPSS: 0.015 (72.3th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 72nd percentile — 72.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2011-3386: held from 0.015 to 0.015.

EPSS over last 30 days · oldest: 0.015 · newest: 0.015 · change: 0.000

Affected products

References